Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global histopathology services market was valued at US$ 34.99 billion in 2021 and is expected to register a revenue CAGR of 5% to reach US$ 56.18 billion by 2030.

Histopathology Services Market Fundamentals 

Histopathology is the study of disease symptoms through microscopic inspection of a biopsy or surgical specimen that is processed and put onto glass slides. The slices are stained with one or more dyes to visualize distinct components of the tissue under a microscope. The histopathology services provide a detailed evaluation of the tissue organization at all levels, from the entire organ down to the molecular components of cells. This technology plays a major role in evaluating implanted medical devices (artificial cartilages, hip and knee prostheses, fusion polymers, and stents) to understand their structural functionalities.

[302785]

Histopathology Services Market Dynamics

The global histopathology services market is expected to register steady revenue growth during the forecast period. This growth is attributed to increase in the preliminary diagnoses of medical conditions due to the increasing number of clinical trials. The revenue growth of this market is also influenced by rising cases of cancer and tissue abnormalities among people across the globe and increasing demand for histopathology services, thus boosting the market revenue growth.

According to a WHO report, nearly 10 million cancer-related deaths were recorded in 2020, resulting in a leading cause of death in the world. Additionally, an increase in implantation procedures due to various factors, such as accidents, age, and others, contributes to the market’s revenue growth. Furthermore, rising demand for biologics also influences the revenue growth of the histopathology services market.

However, limitations associated with histopathology are expected to hamper the market’s revenue growth to some extent.

Histopathology Services Market Ecosystem

The global histopathology services market is analyzed from three perspectives: application, end-user, and region.

Histopathology Services Market by Application

[7463523]

Based on the application, the global histopathology services market is segmented into skin tissue biopsy, liver biopsy, surgical specimen, breast biopsy, gastrointestinal biopsy, a biopsy of gynecological cancers, lung biopsy, testicular biopsy, pancreatic biopsy, and others. 

The surgical specimen segment dominates the market with the largest revenue share. Rising cases of abnormalities in the tissues, thus, increasing the therapeutic surgical removal (sample of the tissue) of diseases area or organs are responsible for boosting the demand for effective diagnosis technology. Histopathology is a crucial part of a diagnostic procedure to provide a specified and detailed analysis of removed tissue lump from the diseased region for better treatment. This factor is propelling overall market development.

The breast biopsy segment is estimated to register lucrative revenue growth during the forecast period. A rise in breast-related problems and increase in the cases of breast lumps and breast cancer among the women population is the influencing factor for this lucrative revenue growth of the segment. Approximately 2.3 million women were diagnosed with breast cancer, with a total of 6,85,000 deaths globally in 2020, according to the statistics provided by the WHO. Thus, positively impacting the overall revenue growth of the histopathology services market. 

Histopathology Services Market by End-user

Based on the end-user, the global histopathology services market is segmented into diagnostic laboratories & reference laboratories, research institutes, and others. 

Histopathology services are widely used to diagnose various types of cancers and chronic diseases. The diagnostic laboratories segment dominates the market owing to increase in the usage of cells and tissues from abnormal lump areas to detect abnormalities and cancer and for cancer screening, such as breast, bowel, and cervical cancer.

Histopathology Services Market by Region

Based on the region, the global histopathology services market is segmented into North America, Europe, Asia Pacific, and the rest of the world. 

North America accounts for the largest revenue share of the global histopathology services market. A large base of patients with chronic diseases and increased demand for biologics highly influence the market’s revenue growth in this region. The ongoing competition within pharmaceutical and biopharmaceutical industries for enhanced biological products and biosimilars and the critical role of histopathology in understanding tumor biology and the harmful mechanisms of numerous bacteria are boosting the demand for histopathology services in this region. 

Europe accounts for the second-largest revenue share of the global histopathology services market, owing to high cancer cases and a rise in the R&D activities in this region. Technological advancements in histopathology services and an increase in funding for different R&D activities and diagnostic tests also encourage market revenue growth. Additionally, the rise in demand for sophisticated tools for histopathology services in healthcare to improve efficiency and the surge in demand for personalized treatment solutions drive the market’s revenue growth. Furthermore, the European Commission Health Program’s cancer project and financial efforts have increased the need for histopathology services in this region. 

Histopathology Services Market Competitive Landscape

The prominent players operating in the global histopathology services market are: 

• Cellular Pathology Services Limited
• Acculabs Diagnostics UK Ltd.
• Great Ormond Street Hospital (GOSH) Laboratory
• HCA Laboratories UK
• Sonic Healthcare Limited
• Targos Molecular Pathology GmbH
• Laboratoire Cerba
• Spire Healthcare Group Plc
• TPL Path Labs
• Unilabs Group Services

Histopathology Services Market Recent Developments

• In February 2021, Hologic Inc. announced its strategic partnership with Google Cloud to use machine learning capabilities in its Genius Digital Diagnostics System. This collaboration aimed at improving cervical cancer screening using machine learning and artificial intelligence (AI).
• In September 2020, Cernostics announced its strategic collaboration with Deciphex to assess the application of AI-driven image analysis tools and technology to improve cancer detection in patients with Barrett's Esophagus. This cooperation combines both firms' technology resources, which were expected to be applied to one of the world's biggest databases of thoroughly annotated histological photos of esophageal tissue from Barrett's Esophagus patients.

Frequently Asked Questions About This Report